Literature DB >> 12766761

Apoptosis as an HIV strategy to escape immune attack.

Marie-Lise Gougeon1.   

Abstract

Viruses have evolved numerous mechanisms to evade the host immune system and one of the strategies developed by HIV is to activate apoptotic programmes that destroy immune effectors. Not only does the HIV genome encode pro-apoptotic proteins, which kill both infected and uninfected lymphocytes through either members of the tumour-necrosis factor family or the mitochondrial pathway, but it also creates a state of chronic immune activation that is responsible for the exacerbation of physiological mechanisms of clonal deletion. This review discusses the molecular mechanisms by which HIV manipulates the apoptotic machinery to its advantage, assesses the functional consequences of this process and evaluates how new therapeutics might counteract this strategy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766761     DOI: 10.1038/nri1087

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  81 in total

1.  Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals.

Authors:  Tae-Wook Chun; J Shawn Justement; Christina Sanford; Claire W Hallahan; Marie A Planta; Mona Loutfy; Shyam Kottilil; Susan Moir; Colin Kovacs; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapy.

Authors:  Jun Zuo; Joseph Church; Marvin Belzer; Christina Kitchen; Bonnie Ank; Ingrid Schmid; Paul Krogstad
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

3.  Commitment to apoptosis in CD4(+) T lymphocytes productively infected with human immunodeficiency virus type 1 is initiated by lysosomal membrane permeabilization, itself induced by the isolated expression of the viral protein Nef.

Authors:  Mireille Laforge; Frederic Petit; Jérôme Estaquier; Anna Senik
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells.

Authors:  Constantinos Petrovas; Yvonne M Mueller; Ioannis D Dimitriou; Susan R Altork; Anupam Banerjee; Peter Sklar; Karam C Mounzer; John D Altman; Peter D Katsikis
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

5.  Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys.

Authors:  M Paiardini; B Cervasi; B Sumpter; H M McClure; D L Sodora; M Magnani; S I Staprans; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 6.  Common threads in persistent viral infections.

Authors:  Melissa Kane; Tatyana Golovkina
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation.

Authors:  Shi-Meng Zhang; Yi Sun; Rong Fan; Qin-Zhi Xu; Xiao-Dan Liu; Xiangming Zhang; Ya Wang; Ping-Kun Zhou
Journal:  FASEB J       Date:  2009-10-13       Impact factor: 5.191

8.  Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha.

Authors:  Biswanath Majumder; Narasimhan J Venkatachari; Elizabeth A Schafer; Michelle L Janket; Velpandi Ayyavoo
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of bcl-2 expression.

Authors:  Subbiah Pugazhenthi; Donald H Gilden; Sreekala Nair; Anne McAdoo; Mary Wellish; Elizabeth Brazeau; Ravi Mahalingam
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

10.  Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.

Authors:  Alicja Dabrowska; Nayoung Kim; Anna Aldovini
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.